The Immunohistochemistry CD79a Test is a specialized diagnostic procedure designed to detect the presence of the CD79a protein in tissue samples. This protein is a critical component of the B-cell antigen receptor complex and is typically expressed on the surface of B cells. The test plays a vital role in the diagnosis and classification of various hematologic malignancies, including different types of lymphomas and leukemias, where the identification of B cells is crucial for accurate diagnosis and treatment planning.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and expert staff, the test involves the application of specific antibodies against CD79a on a tissue section, which is then visualized under a microscope. This allows pathologists to assess the presence and distribution of B cells within the sample, providing valuable information for the diagnosis and management of patients.
The cost of the Immunohistochemistry CD79a Test at DNA Labs UAE is set at 500 AED. This price reflects the sophisticated nature of the test and the expertise required to accurately interpret the results. Patients and healthcare providers looking for reliable diagnostic services in the field of immunohistochemistry can consider DNA Labs UAE as a trusted option for conducting the CD79a test, among other specialized tests.
The Immunohistochemistry CDX-2 test is a specialized diagnostic procedure designed to detect the presence of the CDX-2 protein in tissue samples. CDX-2 is a crucial transcription factor primarily expressed in the nuclei of intestinal epithelial cells and plays a significant role in the development and maintenance of the intestine. Its expression is also a valuable marker for the identification of gastrointestinal tract tumors and can aid in distinguishing between primary and metastatic gastrointestinal cancers.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic services, this test involves the application of specific antibodies against CDX-2 on tissue sections to observe the protein's localization. The presence or absence of CDX-2 staining helps pathologists in diagnosing and classifying tumors, especially in cases where the origin of a metastatic tumor is uncertain.
The cost of the Immunohistochemistry CDX-2 test at DNA Labs UAE is set at 500 AED. This cost reflects the sophisticated nature of the test, including the use of specialized reagents and the expertise required to accurately interpret the results. Patients and healthcare providers seeking detailed insights into gastrointestinal-related cancers may find this test particularly useful for diagnosis and treatment planning.
The Immunohistochemistry Cyclin-D1 Test is a specialized diagnostic procedure used to detect the presence and level of Cyclin-D1 protein in tissue samples. Cyclin-D1 is a crucial protein involved in cell cycle regulation, and its overexpression is often associated with various types of cancers, including breast cancer, mantle cell lymphoma, and multiple myeloma. This test plays a significant role in the diagnosis, prognosis, and sometimes in guiding the treatment strategies for these conditions.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the test involves the application of specific antibodies against Cyclin-D1 on a tissue sample, which is then examined under a microscope. The presence and intensity of staining provide valuable information about the expression levels of Cyclin-D1, helping healthcare professionals make informed decisions about patient care.
The cost of the Immunohistochemistry Cyclin-D1 Test at DNA Labs UAE is 500 AED. The price is reflective of the sophisticated technology and expertise required to accurately conduct the test and interpret the results. Patients seeking this test can expect state-of-the-art services in a patient-centric environment, ensuring high-quality diagnostic care.
The Immunohistochemistry Cytokeratin-20 (CK-20) Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect the presence of CK-20 protein in tissue samples. CK-20 is a type of cytokeratin that is primarily found in the gastrointestinal tract, urothelium, and Merkel cells in the skin, making it a valuable biomarker in identifying and differentiating various types of cancer, including colorectal, gastric, and transitional cell carcinomas. The test involves the application of specific antibodies to a tissue sample, which bind to CK-20 if present, and can be visualized using a microscope after the application of a detection system. This allows pathologists to assess the distribution and intensity of CK-20 expression, providing crucial information for diagnosis, prognosis, and treatment planning. The cost of the CK-20 Test at DNA Labs UAE is 500 AED, making it an accessible option for patients seeking advanced diagnostic services in the region.
The Immunohistochemistry Epidermal Growth Factor Receptor (EGFR) Test is a specialized diagnostic procedure aimed at detecting the presence of EGFR proteins on the surface of cells within tissue samples. EGFR is a critical protein that, when mutated or overexpressed, can play a significant role in the development and progression of various types of cancer, including lung, colorectal, and breast cancers. This test is particularly useful for guiding treatment decisions, as cancers with EGFR mutations may respond well to targeted therapy drugs.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test involves the use of specific antibodies that bind to the EGFR proteins. These antibodies are then visualized using a colorimetric reaction, allowing pathologists to assess the presence and extent of EGFR expression in the tissue sample. The process provides invaluable insights into the molecular profile of the tumor, which can significantly impact the therapeutic approach, offering a more personalized treatment plan for patients.
The cost of the Immunohistochemistry EGFR Test at DNA Labs UAE is set at 500 AED. This investment can be pivotal for patients with certain types of cancer, offering them a clearer path towards effective treatment options tailored to their specific condition.
The Immunohistochemistry Growth Hormone (GH) Test is a specialized diagnostic procedure designed to detect and measure the levels of growth hormone in tissue samples. This test employs immunohistochemistry (IHC) techniques, which involve the use of specific antibodies to identify the presence of GH in tissues, providing critical insights into various conditions related to abnormal growth hormone levels. These conditions can range from growth disorders in children to acromegaly in adults, among others.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic services, the GH test is conducted by experienced professionals who ensure accurate and reliable results. The cost of the test is set at 500 AED, making it accessible for those who need detailed analysis and diagnosis related to growth hormone-related issues. This test is pivotal for clinicians in devising appropriate treatment plans based on precise hormone level readings, contributing significantly to patient care in the realm of endocrinology and beyond.
The Immunohistochemistry Human Chorionic Gonadotropin (HCG) Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting the presence of HCG hormone in tissue samples. Human Chorionic Gonadotropin is a hormone produced during pregnancy, making this test crucial for various medical diagnoses, including confirming pregnancy, diagnosing potential ectopic pregnancies, and identifying certain types of cancers that can produce HCG, such as germ cell tumors.
Utilizing immunohistochemistry (IHC) technology, this test involves the application of antibodies against HCG on tissue sections, which are then visualized under a microscope. This method allows for precise localization of HCG production within the tissue, providing valuable information for diagnostic, prognostic, and treatment planning purposes.
The cost of the Immunohistochemistry Human Chorionic Gonadotropin HCG Test at DNA Labs UAE is 500 AED. This competitive pricing, combined with the lab's reputation for accuracy and reliability, makes it a preferred choice for patients and healthcare providers seeking comprehensive and detailed diagnostic services. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by experienced professionals, ensuring high-quality testing and results you can trust.
The Immunohistochemistry Lambda Light Chains Test is a specialized diagnostic procedure utilized to identify and quantify lambda light chains in tissues. This test plays a crucial role in the diagnosis and monitoring of various conditions, particularly in the assessment of lymphoproliferative disorders and certain types of cancers such as multiple myeloma. By employing immunohistochemistry techniques, this test allows for the precise localization of lambda light chains within tissue samples, offering valuable insights into the pathology of the disease.
Conducted at DNA Labs UAE, a facility renowned for its advanced diagnostic services, the test involves staining tissue sections with antibodies specific to lambda light chains. This enables pathologists to visually assess the presence and distribution of these proteins under a microscope, facilitating accurate diagnosis and treatment planning.
The cost of the Immunohistochemistry Lambda Light Chains Test at DNA Labs UAE is set at 500 AED. This investment in health diagnostics is crucial for patients requiring detailed analysis of their condition, allowing for targeted treatment strategies and improved health outcomes. DNA Labs UAE ensures the reliability and accuracy of the test results, supported by their state-of-the-art technology and expert team of pathologists and technicians.
The Immunohistochemistry Melan-A Test is a specialized diagnostic procedure designed to detect the presence of Melan-A antigen in tissue samples. Melan-A is a protein commonly found in melanocytes, the cells responsible for producing melanin, which gives skin its color. This test plays a crucial role in the diagnosis and study of melanomas, a type of skin cancer originating from melanocytes, as well as in identifying certain types of benign nevi (moles).
Performed in state-of-the-art facilities like DNA Labs UAE, the test involves using antibodies targeted against the Melan-A antigen to stain tissue sections. These antibodies bind to the antigen if present, and with the application of specific detection systems, the bound antibodies can be visualized, indicating the presence of Melan-A protein. This visualization aids pathologists in assessing the sample for diagnostic or research purposes.
The cost of the Immunohistochemistry Melan-A Test at DNA Labs UAE is 500 AED. The test is executed with precision and care by experienced professionals, ensuring reliable results. It's an essential tool in the dermatological and oncological fields, offering critical insights into the nature of skin lesions and contributing to the effective management and treatment of skin cancer patients.
The Immunohistochemistry ATRX Test is a specialized diagnostic procedure used to detect the presence of alterations in the ATRX (alpha-thalassemia/mental retardation syndrome X-linked) gene, which plays a critical role in chromatin remodeling and is often implicated in various types of cancers, including gliomas, pancreatic neuroendocrine tumors, and sarcomas. This test employs immunohistochemistry (IHC) techniques, which involve the use of specific antibodies to identify the ATRX protein within tissue samples. The loss of ATRX protein expression, as revealed by this test, can provide valuable information regarding tumor classification, prognosis, and potential therapeutic strategies.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the Immunohistochemistry ATRX Test is priced at 500 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality and reliable test results. This test is particularly useful for healthcare providers in making informed decisions about patient management and treatment planning, especially in the context of neuro-oncology and other fields where ATRX gene alterations are of clinical significance.
